文献速递骨软组织肉瘤与黑色素瘤

德国皮肤鳞状细胞癌1986-2019年发病率、解剖部位、分期与组织学亚型分析

Cutaneous squamous cell carcinoma 1986-2019 in Germany: Incidence, anatomical site, staging, and histologic subtypes.
PubMed 文献 · Eur J Cancer · 2025-10-18

该研究基于德国四个联邦州1986至2019年确诊的213,935例首次原发性皮肤鳞状细胞癌(cSCC)病例,覆盖约35%德国人口,分析发病率、解剖部位、T分期、组织学亚型及地区差异。结果显示粗发病率从1986至2015年增长超过500%,女性上升更陡,2015年后趋于平台。T1肿瘤占88.6%,但33.5%病例分期数据不完整。

要点

  • cSCC粗发病率1986至2015年增长超500%,女性上升更陡,2015年后趋平台。
  • T1肿瘤占88.6%,但33.5%病例分期数据不完整,存在系统低估。
  • 面部肿瘤最常见,男女发病率相等;梭形细胞和非角化亚型与更晚期相关。

核心结论

  • 德国cSCC发病率显著上升,性别、地区和肿瘤类型间存在显著差异。
  • 需改进登记方案纳入多原发、临床分期和早期原位病变以准确监测。

研究设计与样本

  • 基于德国四个联邦州1986至2019年确诊的213,935例首次原发性cSCC病例,覆盖约35%德国人口。
  • 计算粗发病率和年龄标准化发病率,按性别、解剖部位、组织学亚型、T分期和地区进行亚组分析。

主要发现

  • 粗发病率从1986至2015年增长超过500%,女性上升更陡。
  • 2015年后发病率趋于平台,但萨尔兰州出现延迟上升。
  • 面部肿瘤最常见,男女发病率相等。
  • T1肿瘤占88.6%,但33.5%病例分期数据不完整。
  • 梭形细胞和非角化亚型与更晚期阶段相关。

临床怎么用

  • 临床应关注cSCC发病率持续上升趋势,尤其女性人群。
  • 对梭形细胞和非角化亚型应警惕更晚期风险。
  • 现有登记数据因未计入多原发和原位病变而低估疾病负担,需改进监测。

局限性

  • 癌症登记数据未计入多于一个cSCC及原位癌(如光化性角化病),导致疾病负担系统性低估。
  • 33.5%病例分期数据不完整。
  • 数据仅覆盖德国四个联邦州约35%人口。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cutaneous squamous cell carcinoma (cSCC) is the second most common non-melanoma skin cancer. Population-based data analysis in Germany has largely focused on incidence. Recently analysed datasets covered 4,75 % of the population. OBJECTIVES: To assess incidence, anatomical site- and T-stage distribution, histological subtypes of cSCC in Germany, with a focus on sex- and age-group specific patterns and regional differences. MATERIALS AND METHODS: 213,935 first primary cSCC cases diagnosed between 1986 and 2019 from four federal states of Germany with complete case ascertainment were analysed. The dataset covers ∼35 % of the German population. Crude- and age-standardised incidence rates (CIR, ASIR) were calculated, and subgroup analyses were performed by sex, anatomical site, histological subtype, T-stage and region. RESULTS: CIR increased by > 500 % from 1986 to 2015, with a steeper rise in women. Incidence plateaued after 2015, except for a delayed increase in Saarland. Facial tumours were most frequent, with equal incidence in males and females. T1 tumours predominated (88.6 %), although staging data were incomplete in 33.5 % of cases. Regional and sex-based differences were observed in both T-stage and histological subtypes. Spindle cell and non-keratinising variants were associated with more advanced stages. Cancer registry data did not count more than one cSCC and carcinoma in situ such as actinic keratosis, leading to systematic underestimation of disease burden. CONCLUSIONS: cSCC incidence has risen substantially in Germany, with significant variation by sex, region, and tumour type. Improved registry protocols incorporating multiple primaries, clinical staging, and early in situ lesions are essential for accurate surveillance and healthcare planning.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Balkenhol J, Dirschka T, Falkenberg C, et al. Cutaneous squamous cell carcinoma 1986-2019 in Germany: Incidence, anatomical site, staging, and histologic subtypes. Eur J Cancer. 2025. PMID: 41138353. doi:10.1016/j.ejca.2025.116068

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。